![]() Pharma Two B Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. | ![]() Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. | ![]() Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. | ![]() Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. | ||
Founding Date | Founding Date 2007 | Founding Date 2000 | Founding Date 2009 | Founding Date 1994 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Rehovot, IL HQ | Locations Cambridge, US HQ | Locations Alameda, US HQ | Locations Needham, US HQ Walsrode, DE | |
Employees | Employees 9 | Employees 25 | Employees 4843% increase | Employees 1,14712% decrease | Employees 7328% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 726.1 k | Valuation ($) 10.6 m | Valuation ($) 8.2 b | Valuation ($) 144.9 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income N/A | Net income ($44.4m) (FY, 2022) | Net income ($264.5m) (FY, 2021) | Net income $782.6m (FY, 2025) | Net income ($209.5m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 38m | Total funding raised $ 106.6m | Total funding raised $ 357m | Total funding raised N/A | Total funding raised $ 170m |

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
View company
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View company
Exelixis is an oncology company that develops cancer treatments.
View company
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View company